Latest Data & Signals Issued

Below are some of the latest signals issued for Galera Therapeutics, Inc.

General

Signal Type Signal Value Data
Score 1.156 2 days ( 0 %
Last Price $0.105 0 %
Performance History
7 Days
$0.0881 $0.105
19.18%
30 Days
$0.0918 $0.105
14.44%
12 Mos
$0.0280 $0.105
275.00%

10/18

Active Buy Signals

Specific Signals

Short Term
Net score: 39.19
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.105 - $0.105
Trend - 3 mos -5.71 % High Width: 26.51 %
Pred. range - 3 mos $0.0782 - $0.0989 Low -25.55 % - -5.81 %
Volume Direction Sell High Volume: 17,643 · Direction: 0
Pivot Short Sell Very Low Jul 10, 2026 - 2 days
RSI Short Pivot Signal Sell Very Low Jul 10, 2026 - 2 days
Short MA 3 mos Buy Low Jul 01, 2026 - 8 days
Long MA 3 mos Buy Medium Jul 09, 2026 - 3 days
Short/Long MA 3 mos Buy Medium Jul 10, 2026 - 2 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 85.83
Signal Type Signal Value Importance Data
Trend - 12 mos 266.43 % Very High Width: 114.40 %
Pred. range - 12 mos $0.205 - $0.440 High 95.61 % - 319.39 %
Short MA 12 mos Buy Very High Jul 08, 2026 - 4 days
Long MA 12 mos Buy Very High Feb 17, 2026 - 101 days
Short/Long MA 12 mos Buy Very High Nov 10, 2025 - 167 days
Pivot Long Sell Low Jul 10, 2026 - 2 days
RSI Long Pivot Signal Buy Low Jul 09, 2026 - 3 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Buy High No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Click to get the best stock tips daily for free!
ABOUT GALERA THERAPEUTICS, INC.
Galera Therapeutics
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical trial for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
10.58% Jun 29
NMRK
$15.02
0.466% Jun 24
X
XMAX
$8.34
2.40% Jun 24
NESR
$25.07
12.49% Jun 23
CAG
$13.43
6.70% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE